جست‌وجوی استاد و پژوهشگر

Peter Doshiمشاهده پروفایل

دانشیار

• Clinical Trial Transparency
• Pharmaceutical Policy
• Evidence-Based Medicine
• +۱۰ مورد دیگر

Peter Doshi is an associate professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy and a senior editor at The BMJ . His work bridges academia and public health policy, focusing on clinical trial transparency, drug approval processes, and the integrity of biomedical evidence. Education: A.B. in Anthropology, Brown University A.M. in East Asian Studies, Harvard University Ph.D. in History, Anthropology, and Science, Technology and Society, MIT Fellowship in Comparative Effectiveness Research, Johns Hopkins University His research interests include clinical trial transparency , evidence-based medicine , vaccine policy , and pharmaceutical regulation . He has extensively analyzed the use of regulatory data in systematic reviews, particularly in influenza antivirals and COVID-19 vaccines. His work challenges assumptions about drug efficacy and calls for greater access to raw clinical trial data. Doshi's recent publications reveal a strong trend toward analyzing methodological flaws in vaccine trials, regulatory oversight, and bias in observational studies. He consistently advocates for transparency and scientific rigor in public health decision-making. Scientific Awards: New Investigator Award, American Association of Colleges of Pharmacy (2015) Included in The Wired 'Smart List' (2013) Doshi leads the RIAT Support Center (Restoring Invisible and Abandoned Trials), funded by the Laura and John Arnold Foundation, which aims to correct the scientific record by promoting accurate and complete trial reporting. He has received grants from PCORI, Cochrane, NIHR, and CIHR. He has served on advisory panels for the European Medicines Agency and presented to the Institute of Medicine. He frequently contributes to public discourse through op-eds in The New York Times , The BMJ , and testimony before regulatory bodies.

• Reproductive Biology
• Pharmacology
• Obstetrics and Gynecology
• +۵ مورد دیگر

Scott Barnett serves as an Assistant Professor in the Department of Biochemistry & Molecular Biology at the University of Nevada, Reno, focusing on molecular pathways in uterine physiology to combat preterm labor through novel drug development. His academic credentials include: B.S. from University of Nevada, Reno (2011) Ph.D. from University of Nevada, Reno School of Medicine (2017) Dr. Barnett's research centers on reproductive pharmacology, specifically developing placenta-impermeable tocolytics targeting myometrial relaxation mechanisms. His work integrates molecular biology, smooth muscle physiology, and translational drug discovery to address the critical unmet need for FDA-approved preterm labor treatments. Key approaches include modulation of β3 adrenergic receptors, connexin 43 dynamics, and mechanosensitive ion channels like Piezo1 and TREK-1. Analysis of his publication record reveals consistent innovation in dual-pathway targeting strategies, with recent emphasis on small-molecule modulators of endoplasmic reticulum trafficking (Cx43/OXTR) and synergistic ion channel activation. His nephrology-related work demonstrates parallel expertise in multi-target therapeutics for diabetic complications. Dr. Barnett holds a provisional patent for a preterm labor treatment, reflecting his translational impact. While no formal advisees are documented, his program actively develops novel therapeutics and previously explored dual-purpose nephrology drugs. Research is supported by patent-protected innovation and likely grant funding for molecular obstetrics. His laboratory focuses on human myometrial tissue studies, combining molecular signaling analysis with functional contractility assays to bridge basic science and clinical obstetrics.

Kerstin Noëlle Vokingerمشاهده پروفایل

استاد

• Regulatory Sciences
• Health Policy
• Biomedical Ethics and Law
• +۳ مورد دیگر

Prof. Kerstin Noëlle Vokinger is a double professor at the University of Zurich and ETH Zurich, holding positions in Law and Medicine. She leads the Chair for Regulation in Law, Medicine, and Technology, focusing on interdisciplinary research at the intersection of law, medicine, and technology. Her roles include advising governments and international organizations like the WHO on drug pricing, AI in healthcare, and regulatory frameworks. Education: - MD and JD from University of Zurich - PhD in Biomedical Ethics and Law (University of Zurich) - Habilitation in Medicine (University of Zurich) - LL.M. from Harvard Law School Research Interests: Vokinger's work addresses drug pricing policies, regulatory sciences, AI in healthcare, and global health equity. She has published extensively on topics such as cancer drug economics, AI medical device regulation, and WHO essential medicines policies. Her research bridges legal, medical, and technological challenges to improve access to healthcare technologies. Awards: - 2022 Swiss Science Prize Latsis (most prestigious national award for under-40 researchers) - 2021 Eccellenza Grant from Swiss National Science Foundation Grants & Advising: - Advises UN agencies, WHO, and Swiss government on pharmaceutical policy. - Funded projects include studies on gene therapy pricing, drug shortages, and AI lifecycle regulation. Labs & Teams: Her team at ETH and UZH combines law, medicine, and data science to tackle regulatory challenges in healthcare innovation.

Jeffrey P. Kahnمشاهده پروفایل

استاد

• Bioethics
• Ethics and Public Health
• Ethics and Research
• +۷ مورد دیگر

Jeffrey P. Kahn is the Robert Henry Levi and Ryda Hecht Levi Professor at Johns Hopkins University, with a primary appointment in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. He is a core faculty member at the Johns Hopkins Berman Institute of Bioethics, where he leads research on the ethical, legal, and social implications of emerging biomedical technologies. PhD, Georgetown University, 1989 MPH, Johns Hopkins Bloomberg School of Public Health, 1988 Dr. Kahn’s research focuses on bioethics and public health, with particular expertise in ethics and genomics, research ethics, science policy, and the governance of digital health technologies. His work addresses critical questions about informed consent, equity in access to genomic medicine, public trust in biobanking, and the ethical use of data in public health surveillance. He has led major initiatives such as the Genomic Uses in Infectious Diseases and Epidemics (GUIDE) project and research on digital contact tracing governance. His recent publications reveal a strong trend toward interdisciplinary scholarship, integrating insights from law, policy, history, and social sciences to address complex challenges at the intersection of genetics, infectious diseases, and public health. Themes include anticipatory governance of genome editing, regulatory innovation for rare diseases, and ethical frameworks for decentralized biobanking and digital health applications. Member, Delta Omega Honorary Society in Public Health, Alpha Chapter (Johns Hopkins Bloomberg School of Public Health), 2014 Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy, 2011–present Dr. Kahn has mentored numerous scholars and contributed to national and international policy discussions on bioethics. He has received continuous research funding for projects exploring the ethical dimensions of biobanking, genomic surveillance, and public engagement in science. His leadership extends to collaborative networks such as the BRIDGES Collaboratory, which advances ethical, legal, and social studies at the nexus of infectious and genetic diseases. He is actively involved in research centers including the Johns Hopkins Berman Institute of Bioethics and leads projects that integrate ethics into public health practice and policy development.

Wilson W. Wongمشاهده پروفایل

استاد

• Synthetic Biology
• Immunotherapy
• Gene Circuit Engineering
• +۵ مورد دیگر

Wilson W. Wong is a Professor in the Department of Biomedical Engineering at Boston University's College of Engineering. His research focuses on synthetic biology and engineering cellular therapies, particularly CAR T and CAR-NK cells for cancer, diabetes, and vaccine applications. He leads the Wilson Wong Lab, developing genetic circuits for precise control of cell functions through molecular, chemical, and optogenetic tools. Key achievements include FDA-approved drug-gated circuits, light-inducible recombinases, and saRNA platforms for reduced immunogenicity. Education: PhD in Chemical Engineering (UCLA), B.S. in Chemical Engineering (UC Berkeley). Awards include the Allen Distinguished Investigator Award (2022), NAE German-American Frontiers Invitee (2021), and NIH Director’s New Innovator Award (2013). He collaborates with institutions like MIT and Harvard on lung regeneration projects through the Allen Distinguished Investigators program. Research Highlights: Logic-gated CAR therapies, optogenetic cell patterning, and saRNA-based vaccines Lab Members: Supervises students including Cristina, Huishan, Josh, and Justin Letendre Grants: Allen Foundation, NSF CAREER Award, NIH funding His work bridges synthetic biology with clinical translation, emphasizing spatiotemporal control of cell functions for regenerative medicine and oncology. Recent breakthroughs include multiplex light-inducible circuits and saRNA modifications enhancing therapeutic efficacy.

• Medicinal Chemistry
• Organic Synthesis
• Cancer Therapeutics
• +۵ مورد دیگر

Dr. Daniel Alencar Rodrigues is a Lecturer at the Royal College of Surgeons in Ireland (RCSI) in the School of Pharmacy and Biomolecular Sciences. He holds a PhD in Chemistry from the Federal University of Rio de Janeiro and has held academic positions including Assistant Professor (2017–2018) and Postdoctoral Researcher (2020–2023). His research focuses on medicinal chemistry, organic synthesis, and cancer therapeutics, particularly targeting histone deacetylases (HDACs), phosphatidylinositol-3-kinase (PI3K), and the development of Proteolysis Targeting Chimeras (PROTACs). Education: PhD in Chemistry, Federal University of Rio de Janeiro (2015–2019) MSc in Chemistry, Federal University of Rio de Janeiro (2013–2015) Bachelor in Pharmacy, Federal University of Goiás (2008–2012) Postgraduate Diploma in Health Professions Education, RCSI (2023–2024) His research interests include: Design and synthesis of multi-target drugs and PROTACs for cancer therapy HDAC6 inhibition in breast and brain cancers Computational chemistry for drug design (molecular docking, virtual screening) Development of novel anticancer agents targeting metabolic vulnerabilities Dr. Rodrigues has received the Government of Ireland Postdoctoral Fellowship and has a robust publication record with over 20 peer-reviewed articles. His lab employs a multidisciplinary approach combining organic synthesis, computational modeling, and biological evaluation. Teaching responsibilities include lecturing in the Master of Pharmacy (MPharm) and BSc in Advanced Therapeutic Technologies programs, with a focus on musculoskeletal and haematological health modules. He emphasizes constructive alignment in teaching practices.

Lena Lopez Bradleyمشاهده پروفایل

استادیار

• Couples therapy
• At-risk youth
• Anger management
• +۵ مورد دیگر

Lena Lopez Bradley is an Assistant Professor in the Department of Counseling and Family Sciences at Loma Linda University, where she also serves as Director of the Marital & Family Therapy MS and Counseling MS with Drug & Alcohol Counseling Certificate (Dual Degree) Programs. She holds a PhD in Marriage and Family Therapy (2013) and MS in Marriage and Family Therapy (2003), both from Loma Linda University. Her areas of specialization include couples therapy, at-risk youth, anger management, crisis intervention, clinical supervision, school-based programs, and program development. She is a Certified Triple P (Level 4) Facilitator, certified in Cognitive Behavioral Intervention for Trauma in Schools, and certified in Cognitive Behavioral Treatment for Late-Life Depression. She is a Licensed Marriage and Family Therapist (LMFT #45615), an AAMFT Clinical Fellow and Approved Supervisor, and actively involved in the American Association for Marriage and Family Therapy (AAMFT) and California Association of Marriage and Family Therapists (CAMFT). Her current research focuses on the Three-tier Systemic Supervision Process. She emphasizes practical clinical training and community-oriented program development.

• Rheumatology
• Autoimmune Diseases
• Reproductive Health
• +۳ مورد دیگر

Laura Andreoli is an Adjunct Professor at the University of Southern Denmark's Department of Regional Health Research, affiliated with the Danish Hospital for Rheumatic Diseases and the Danish Centre for Expertise in Rheumatology in Sønderborg. Her research focuses on autoimmune diseases, particularly their management during reproductive phases such as pregnancy and lactation. She has contributed to major international guidelines, including the EULAR 2024 update on antirheumatic drug use in reproductive health contexts. Her work also addresses vaccine safety in autoimmune patients and the long-term outcomes of children born to mothers with rheumatic conditions. Key research areas include drug safety during pregnancy, maternal-fetal health, and clinical guideline development. Recent studies include the COVAD project assessing SARS-CoV-2 vaccine safety and analyses of conflicting drug information affecting healthcare provider decisions. Her findings have been widely cited and featured in news outlets and social media platforms.

Phillip D. Zamoreمشاهده پروفایل

استاد

• RNA Interference
• Small RNA Biology
• piRNA Pathways
• +۳ مورد دیگر

Phillip D. Zamore serves as Chair and Professor of the RNA Therapeutics Institute at the University of Massachusetts Chan Medical School School of Medicine and is an Investigator of the Howard Hughes Medical Institute. He holds the Gretchen Stone Cook Professorship in Biomedical Sciences and leads pioneering research in RNA biology. Dr. Zamore earned his A.B. (1986) and Ph.D. (1992) in Biochemistry and Molecular Biology from Harvard University, followed by postdoctoral training at The Whitehead Institute for Biomedical Research. His research focuses on small RNA silencing pathways including RNA interference (RNAi), microRNA, and PIWI-interacting RNA (piRNA) mechanisms across eukaryotic and prokaryotic systems. Key investigations explore how Argonaute proteins achieve sequence-specific regulation of transcription and translation, with emphasis on piRNA biogenesis in germ cells and bacterial Argonaute functions. Analysis of his recent publications reveals dominant themes in transposon silencing, piRNA pathway evolution, RNA therapeutic development, and molecular mechanisms of gene regulation. His work bridges fundamental biochemistry with clinical applications, particularly in RNA-based therapies for genetic disorders. Notable scientific honors include: Chancellor’s Medal for Excellence in Scholarship (2015) Dean's Award for Research Mentoring (2011) Fellow of the National Academy of Inventors (2014) Election to the American Academy of Arts & Sciences, National Academy of Sciences, and National Academy of Medicine (2023) Dr. Zamore has co-founded multiple biotechnology companies including Alnylam Pharmaceuticals (2002), which developed the FDA-approved RNAi therapeutic ONPATTRO for hereditary transthyretin-mediated amyloidosis, and Voyager Therapeutics (2014). His laboratory has trained dozens of researchers now leading institutions worldwide, with over 150 publications and 119 patents reflecting his translational impact. Current research leverages biochemical and genetic approaches to develop RNA-guided therapies for diseases like Huntington's. The Zamore Laboratory operates within the RNA Therapeutics Institute at UMass Chan Medical School, utilizing advanced genomic, biochemical, and imaging technologies to study small RNA pathways in model organisms including Drosophila, mice, and bacterial systems.

Gerard Porterمشاهده پروفایل

مدرس ارشد

• Medical Law
• Medical Ethics
• Patent Law
• +۷ مورد دیگر

Gerard Porter is a Senior Lecturer in Medical Law & Ethics at the University of Edinburgh's School of Law. He serves as the Programme Director of the online LLM in Medical Law and Ethics. His academic career spans multiple institutions, with visiting fellowships at the Centre for Biomedical Ethics at the National University of Singapore and the Program on Science, Technology and Society at the John F. Kennedy School of Government, Harvard University. Dr. Porter's educational background includes: LL.B. in Law and Japanese from Cardiff University LL.M. in International Economic and Business Law from Kyushu University, Japan Dr. Porter's research focuses on the intersection of law, ethics, and healthcare, with particular expertise in medical law, patent law, and the regulation of life sciences. His work demonstrates a strong comparative dimension, especially regarding Japanese legal frameworks. He has made significant contributions to understanding how legal systems address emerging healthcare challenges, from stem cell research to antimicrobial resistance. His research often examines the balance between innovation, patient safety, and ethical considerations in medical practice. His scholarly output reveals evolving trends in health law scholarship, with early work focusing on patent law and stem cell research regulation, shifting toward contemporary issues like medical apologies, clinical trial regulation in developing economies, and the ethical implications of genetic testing. His recent publications show increasing attention to global health law challenges, including pandemic response frameworks and antimicrobial resistance governance. Dr. Porter has actively contributed to academic leadership through directing the online LLM program in Medical Law and Ethics. While specific grant information isn't detailed in the available materials, his international collaborations suggest involvement in cross-border research initiatives addressing global health law challenges. With expertise spanning multiple jurisdictions and legal traditions, Dr. Porter maintains strong connections with Japanese legal scholarship while contributing to European and global health law discourse. His work bridges theoretical legal analysis with practical healthcare applications, making significant contributions to both academic and policy conversations in medical law and ethics.

Al-Hafeez Z Dhallaمشاهده پروفایل

استادیار

• Biomedical Optics
• Optical Coherence Tomography
• Scanning Laser Ophthalmoscopy
• +۶ مورد دیگر

Al-Hafeez Z Dhalla serves as an Assistant Research Professor in the Department of Biomedical Engineering at Duke University and is a Faculty Network Member of the Duke Institute for Brain Sciences. His academic appointment reflects his engineering expertise in translating optical technologies to clinical ophthalmology applications. He earned his Ph.D. from Duke University in 2012, establishing a foundation for his specialized work in biomedical optics. This educational trajectory directly informs his current research and teaching activities within the university's engineering framework. Dr. Dhalla's research program centers on developing optical coherence tomography (OCT), scanning laser ophthalmoscopy (SLO), and LiDAR systems for non-invasive, high-resolution biological tissue imaging. His laboratory specifically targets ophthalmic disease diagnosis and treatment, with strong emphasis on engineering novel instrumentation for image-guided surgery and robotic microsurgery. A critical aspect of his work involves preparing these technologies for commercialization through rigorous clinical validation and regulatory approval processes, bridging the gap between engineering innovation and medical practice. His publication portfolio demonstrates consistent advancement in optical imaging technologies, particularly handheld OCT devices, real-time volumetric surgical imaging, and adaptive optics for photoreceptor visualization. The research exhibits a clear trajectory from fundamental optical engineering toward clinical implementation, with recurring themes of enhancing surgical precision through robotic integration and improving diagnostic capabilities via novel scanning methodologies. Within the educational sphere, Dr. Dhalla teaches multiple courses including BME 791 (Graduate Independent Study), BME 590 (Special Topics), BME 494/493 (Projects in Biomedical Engineering), and BME 436L (Biophotonic Instrumentation), directly connecting his research expertise to student training in optical instrumentation and biomedical device development.

Steven Goodmanمشاهده پروفایل

استاد

• Epidemiology
• Biostatistics
• Clinical Research Methods
• +۴ مورد دیگر

Steven Goodman is a Professor of Epidemiology and Population Health, and Medicine at Stanford University, serving as Associate Dean of Clinical and Translational Research. He leads initiatives like the Stanford Program on Research Rigor and Reproducibility (SPORR) and co-directs the Meta-research Innovation Center at Stanford (METRICS). His research focuses on improving research reproducibility, evidence synthesis, and clinical trial methodology. Goodman holds academic appointments in multiple departments and has served on prestigious committees such as the National Academy of Medicine and the Patient-Centered Outcomes Research Institute (PCORI). Educationally, he earned an AB from Harvard, an MD from NYU, and advanced degrees in Biostatistics and Epidemiology from Johns Hopkins. He has authored over 200 publications, emphasizing Bayesian methods, ethical research practices, and meta-research. His awards include the Abraham Lilienfeld Award and induction into the National Academy of Medicine. Goodman teaches courses on clinical research methods, scientific inference, and diagnostic technologies. Key contributions include advancing open science practices, data-sharing policies, and critical analyses of FDA decision-making. His work bridges statistical rigor with practical applications in healthcare, aiming to enhance the reliability and relevance of biomedical research.

Aaron Baughمشاهده پروفایل

استادیار

• Pulmonary Medicine
• Critical Care
• Health Disparities
• +۴ مورد دیگر

Dr. Aaron Baugh is an Assistant Professor in the Department of Pulmonary & Critical Care Medicine at the University of California, San Francisco (UCSF) School of Medicine. His research focuses on improving care for asthma and COPD patients from low-income and racial/ethnic minority backgrounds, emphasizing how social disparities influence lung disease outcomes. He completed his BS in Brain, Behavior, and Cognitive Science at the University of Michigan, followed by an MD from the University of Toledo College of Medicine, residency in Internal Medicine, and fellowship in Pulmonary & Critical Care Medicine at UCSF. His research spans topics including healthcare disparities in lung cancer screening, race-neutral lung function interpretation, and social determinants of respiratory health. Notable work includes analyzing trends in sarcoidosis mortality among U.S. veterans and evaluating cardiopulmonary exercise testing for lobectomy candidates. He advocates for race-neutral approaches in pulmonary diagnostics to reduce health inequities. Dr. Baugh's publications highlight intersections of race, socioeconomic status, and respiratory disease management. Areas of focus include improving spirometry interpretation practices, addressing COPD-related multimorbidity in impoverished populations, and reforming medical education to prioritize diversity and inclusion.

• Pharmacogenomics
• Pharmacist-led interventions
• Pharmacy education
• +۵ مورد دیگر

Dr. Chiao Xin Lim is a Senior Lecturer in the Department of Health and Biomedical Sciences at RMIT University. Her research focuses on pharmacogenomics implementation, culturally competent healthcare interventions, digital health innovation, and pharmacy education. She coordinates third-year undergraduate pharmacy practice courses and supervises research projects addressing medication adherence in culturally diverse populations. Professional roles include General Council member and Education Representative for the Australasian Pharmaceutical Science Association (2023-24) and membership in the Pharmaceutical Society of Australia. Key research interests span asthma self-management in Middle Eastern Arabic-speaking refugees, palliative care pharmacist roles, and educational strategies for cultural competence in health professions. Dr. Lim's teaching innovations include case-based learning for cultural competence and interprofessional simulations between nursing/pharmacy students. She has pioneered validated tools for asthma inhaler technique assessment in Arabic-speaking populations and developed survey instruments for oncology pharmacogenomics education needs. Supervision Focus: Culturally responsive healthcare strategies for cardiovascular, diabetes, and respiratory conditions Key Projects: Pharmacogenomics implementation in oncology, digital health interventions for medication adherence, and policy analysis for asylum seeker health equity Labs/Teams: Actively involved in multidisciplinary research teams addressing healthcare disparities and pharmacist-led interventions. Collaborates with international partners on translational research projects.

• Intellectual Property Law
• Patent Law
• Artificial Intelligence and Law
• +۳ مورد دیگر

S. Sean Tu is a Professor at West Virginia University College of Law, where they contribute significantly to intellectual property law scholarship through the Law Faculty Scholarship program. Their research focuses on patent law with particular expertise in patent examination processes, examiner behavior, and statistical analysis of patent office operations. Their research interests span intellectual property law, patent law, artificial intelligence applications in legal contexts, pharmaceutical patents, and copyright law. Tu's work demonstrates sophisticated analysis of patent examiner metrics, litigation outcomes, and the impact of examiner interviews on patent prosecution efficiency. They've developed novel metrics like Office Actions per Grant Ratio (OGR) and examined gender disparities in pharmaceutical patent law. Analysis of Tu's publications reveals a strong trend toward empirical patent law research with increasing focus on AI applications in legal reasoning and copyright assessment. Their work bridges legal theory with practical patent office operations, particularly examining how examiner behavior affects patent quality and litigation outcomes. Recent publications show growing interest in pharmaceutical patent issues and AI's role in legal analysis. Tu actively contributes to legal education discussions, particularly regarding AI's impact on legal research and writing. Their scholarship demonstrates engagement with both theoretical legal frameworks and practical applications in patent examination and intellectual property enforcement.